Sarepta Therapeutics: Say Hello To The New CEO

A July 19 conference call with investors regarding this drug maker’s second quarter financial results will be the time most investors hear from the company’s new CEO. What else should investors expect from the call?
Source: Barrons

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>